Patients with early-stage colon cancer (T1-T2) had statistically significant higher numbers of total MVs, TF-positive MVs, EMVs, combined EMV/TF MVs, MUC-1-positive MVs, and combined MUC-1/TF MVs (Figure 2A,B). This evidence concerns the gene MUC1 and colonic neoplasm.